In trypanosomatids, trypanothione replaces glutathione in all glutathionedependent processes. Of the two enzymes involved in the glyoxalase pathway, glyoxalase I and glyoxalase II, the latter shows absolute specificity towards trypanothione thioester, making this enzyme an excellent model to understand the molecular basis of trypanothione binding. Cloned glyoxalase II from Leishmania infantum was overexpressed in Escherichia coli, purified and crystallized. Crystals belong to space group C222 1 (unit-cell parameters a = 65.6, b = 88.3, c = 85.2 Å ) and diffract beyond 2.15 Å using synchrotron radiation. The structure was solved by molecular replacement using the human glyoxalase II structure as a search model. These results, together with future detailed kinetic characterization using lactoyltrypanothione, should shed light on the evolutionary selection of trypanothione instead of glutathione by trypanosomatids.
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Introduction
Trypanosomatids, the causal agents of several human and animal diseases worldwide, present two characteristics that set them apart from all other living organisms. Firstly, glycolysis, the most fundamental biochemical pathway, occurs in these organisms within a specific organelle, the glycosome (Hannaert et al., 2003) . Secondly, the unique thiol N 1 ,N 8 -bis(glutathionyl)spermidine (trypanothione) replaces glutathione in similar eukaryotic glutathione-dependent reactions (Muller et al., 2003; Fairlamb & Cerami, 1992) . These differences may be exploited in the development of novel therapeutic strategies, considering that diseases caused by trypanosomatids have no effective curative therapies and are often lethal. Synergistic effects of simultaneous inhibition of multiple trypanothione-dependent enzymes might prove to be the best option, given the absolute need for this thiol during the life cycle of the parasite (Oza et al., 2003) .
The glyoxalase pathway is one of the important systems that depend on trypanothione. In trypanosomatids, this system is composed of the two enzymes glyoxalase I (lactoylglutathione lyase; EC 4.4.1.5) and glyoxalase II (hydroxyacylglutathione hydrolase; EC 3.1.2.6), which are specific for trypanothione and lactoyltrypanothione, respectively (Sousa Silva et al., 2005; Irsch & KrauthSiegel, 2004) . Glyoxalase II shows absolute specificity towards trypanothione thioester, in contrast to glyoxalase I, which can also react with glutathione-methylglyoxal hemithioacetal (Sousa Silva et al., 2005) . Thus, it is an excellent model to understand the molecular basis of trypanothione specificity.
L. infantum glyoxalase II is a monomeric protein with 295 residues (molecular weight 32.5 kDa) and shares 35% homology with the human glutathione-dependent glyoxalase II (Cameron et al., 1999) . Here, we report the purification, crystallization and preliminary X-ray diffraction analysis of L. infantum glyoxalase II. Its structure determination will shed some light onto the structure-function relationships of the trypanothione-dependent glyoxalase II.
Materials and methods

Cloning, expression and purification
The LiGLO2 gene was amplified from L. infantum (clone MHOM/ MA67ITMAP263) genomic DNA. The PCR product was cloned into the NdeI/XhoI-digested expression vector pET-28a (Novagen), which was then transformed into Escherichia coli BL21-Codon Plus (Stratagene). For overexpression of His 6 -glyoxalase II, BL21-Codon Plus transformants were grown in LB medium containing 50 mg ml À1 kanamycin and 100 mg ml À1 chloramphenicol at 310 K. When the culture reached an OD 600 nm of 0.6, expression was induced with 0.2 mM isopropyl -d-thiogalactopyranoside (IPTG) for 3 h at 310 K. The fusion protein, with an N-terminal tail of six histidines and a thrombin cleavage site (the total tag sequence including linker and cleavage site is HHHHHHSSGLVPRGSH), was purified at 277 K by chromatography on a His-Bind resin (Novagen) column. His 6 -LiGLO II was eluted with an imidazole gradient from 5 mM to 1 M at a flow rate of 2.5 ml min
À1
. Fractions containing glyoxalase II (confirmed by SDS-PAGE) were pooled and the buffer was exchanged to 1Â PBS pH 7.4 using PD-10 columns (Amersham Biosciences). The purity of the recombinant glyoxalase II was estimated by SDS-PAGE. The His 6 -LiGLO II was concentrated to 25 mg ml À1 in 10 mM HEPES pH 7.0 using Amicon Ultra-4 filters (10 000 NMWL; Millipore Corporation).
Crystallization
Crystallization conditions were obtained with an in-house screen of 80 conditions at 293 K, applying the hanging-drop vapour-diffusion method using the crystallization tools from Nextal Biotechnology. Drops were prepared by mixing 2 ml protein solution with 2 ml of each precipitant solution equilibrated over 700 ml reservoir solution. Several conditions in the crystallization screen produced crystals. Crystals were obtained from various conditions including PEGs of molecular weight ranging from 400 to 8000, MES or MOPS with pH between 5.5 and 7.0 and sodium or ammonium acetate as salt components. The best crystals were obtained by mixing 1 ml protein solution with 2 ml reservoir solution containing 30%(w/v) PEG 8000, 0.2 M magnesium chloride and 0.1 M sodium acetate buffer pH 5.5. This final crystallization condition resulted in thick plates, which grew within 2 d to maximum dimensions of approximately 0.16 Â 0.06 Â 0.02 mm at 288 K (Fig. 1). 
Data collection and processing
Crystals were directly flash-cooled in the cryostream without any additional cryoprotectant. All data were collected at 100 K. A lowresolution data set was collected in-house using a Cu K EnrafNonius rotating-anode generator operated at 5 kW and a MAR Research image-plate detector (Table 1) . A high-resolution native data set was measured at beamline ID14-1 at the European Synchrotron Radiation Facility (ESRF) in Grenoble (France) using an ADSC Quantum 4R CCD detector. The crystal diffracted beyond 2.15 Å .
The diffraction experiments showed that glyoxalase II crystals belong to space group C222 1 , with unit-cell parameters a = 65.7, b = 88.3, c = 85.2 Å .
The data were processed using MOSFLM v.6.2.5 (Leslie, 1992) and scaled using SCALA from the CCP4 program package v.6.0 (Collaborative Computational Project, Number 4, 1994). In order to estimate the protein content of the asymmetric unit, the Matthews coefficient V M (Matthews, 1968) and solvent content were calculated based on a subunit molecular weight of 32.5 kDa (predicted from the sequence). The structure was solved by molecular replacement using the full structure of the human homologue (PDB code 1qh3; after removing all non-protein atoms) as a search model and the program Phaser (Read, 2001 ) from the CCP4 suite.
Results and discussion
The L. infantum LiGLO2 gene (GenBank accession No. DQ294972) was cloned and expressed in E. coli BL21 Codon Plus cells. The protein was expressed with an N-terminal His-tag fusion. A nickel-affinity column was used for purification. The purity of the recombinant L. infantum His-glyoxalase II was !95% as estimated by SDS-PAGE, which showed a single band corresponding to a molecular weight of about 32 kDa.
After optimization of the crystal-growth process, the purified protein produced thick plate crystals within 2 d (Fig. 1) which diffracted beyond 2.15 Å resolution using synchrotron radiation. The crystals belong to space group C222 1 , with unit-cell parameters a = 65.7, b = 88.3, c = 85.2 Å . The calculated Matthews coefficient is 1.88 Å 3 Da
À1
, corresponding to a solvent content of $35%, assuming the presence of one molecule in the asymmetric unit (Matthews, 1968) . Data-collection and processing statistics are shown in Table 1 .
Molecular replacement was performed using the human glyoxalase II structure (Cameron et al., 1999 ; PDB code 1qh3; the full model was used), which shows 35% sequence identity with the L. infantum glyoxalase II, as a search model and the molecular-replacement program Phaser (Read, 2001) . One clear solution was obtained and the calculated phases were improved using Pirate (Cowtan, 2000) . A preliminary C trace was manually built from the search model and is currently being rebuilt using COOT (Emsley & Cowtan, 2004) and refined with REFMAC5 from the CCP4 suite (Collaborative Computational Project, Number 4, 1994). Crystals of L. infantum glyoxalase II. 
